Abstract
We reported previously that granulocyte colony-stimulating factor (G-CSF) can promote the invasion ofhuman lung cancer cell lines in vitro. However, the exact mechanism of its stimulatory effect on invasionremains to be elucidated. In the present study we mainly focused our attention on the components of theplasminogen activation system in human lung cancer cell lines, because of the central role that plasminogenactivators play in regulating extracellular proteolysis. We showed that G-CSF induced a dose-dependentincrease in the urokinase-type plasminogen activator (uPA) activity in the conditioned medium of a PC-9lung cancer cell line. When the amounts of uPA activity were quantitated by densitometry, we found thateven at a concentration of 0.01 mg/ml, G-CSF had a stimulatory effect on the uPA release, while highconcentrations caused a 3.6-fold increase at a maximum concentration of 1 mg/ml. A Western blot analysisof the conditioned medium confirmed the findings observed in a zymographic analysis. The observed increasein uPA protein was paralleled by a significant increase in the uPA mRNA levels after treatment withG-CSF. However, our experiments failed to identify any alteration in the plasminogen activator inhibitor(PAI) secretion caused by G-CSF. In addition, we also found the expression of G-CSF receptor by PC-9cells, suggesting the possible pathway activated by G-CSF.©Kluwer Academic Publishers
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Testa JE and Quigley JP, 1990, The role of urokinasetype plasminogen activator in aggressive tumor cell behavior. Cancer Metastasis Rev, 9, 353-67.
Mignatti P and Rifkin DB, 1993, Biology and biochemistry of proteinases in tumor invasion. Physiol Rev, 73, 161-95.
Cubellis MV, Wun TC and Blasi F, 1990, Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBO J, 9, 1079-85.
Petersen LC, Lund LR, Nielsen LS, et al, 1988, One chain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or no intrinsic activity. J Biol Chem, 263, 11189-95.
Harmenberg J, Hoglund M and Hellstrom-Lindberg E, 1994, G-and GM-CSF in oncology and oncological haematology. Eur J Haematol, 52, 1-28.
Thacker JD, Dedhar S and Hogge DE, 1994, The effect of GM-CSF and G-CSF on the growth of human osteosarcoma cells in vitroand in vivo. Int J Cancer, 56, 236-43.
Pei XH, Nakanishi Y, Takayama K, et al. 1996, Granulocyte-colony stimulating factor promotes invasion by human lung cancer cell lines in vitro. Clin Exp Metastasis, 14, 351-7.
Heussen C and Dowdle EB, 1980, Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Analyt Biochem, 102, 196-202.
Faber-Elman A, Mishkin R and Schwartz M. 1995, Components of the plasminogen activator system in astrocytes are modulated by tumor necrosis factor-β and interleukin-1β through signal transduction pathways. J Neurochem, 65, 1524-35.
Nakajima-Iijima S, Hamada H, Reddy P and Kakunaga T, 1985, Molecular structure of the human cytoplasmic β-actin gene; interspecies homology of sequences in the introns. Proc Natl Acad Sci, USA, 82, 6133-7.
Fukunaga R, Seto Y, Mizushima S and Ngata S, 1990, Three different mRNAs encoding human granulocyte colony-stimulating factor receptor. Proc Natl Acad Sci, USA, 87, 8702-6.
Riccio A, Grimaldi G, Verde P, et al.1985, The human urokinase-plasminogen activator gene and its promoter. Nucleic Acids Res, 13, 2759-71.
Niedbala MJ and Picarella MS, 1991, Tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator mediated proteolysis of extracellular matrix and its antagonism by γ-interferon. Blood, 79, 678-87.
Laug, WE, Cao XR, Yu YB, et al.1993, Inhibition of invasion of HT1080 sarcoma cells expressing recombinant plasminogen activator inhibitor 2. Cancer Res, 53, 6051-7.
Baker MS, Bleakley P, Woodrow GC and Doe WF, 1990, Inhibition of cancer cell urokinase plasminogen activator by its specific inhibitor PAI-2 and subsequent effects on extracellular matrix degradation. Cancer Res, 50, 4676-84.
Cajot JF, Bamat J, Bergonzelli GE, et al. 1990, Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells. Proc Natl Acad Sci, USA, 87, 6939-43.
Laug WE, 1985, Inhibition of human tumor cell-associated fibrinolysis by vascular bovine smooth muscle cells. J Natl Inst Cancer, 75, 345-52.
Cross M and Dexter TM, 1991, Growth factors in development, transformation, and tumorigenesis. Cell, 64, 271-80.
Nishizawa M, Tsuchiya M, Watanabe-Fukunaga R and Nagata S, 1990, Multiple elements in the promotor of granulocyte colony-stimulating factor gene regulate its constitutive expression in human carcinoma cells. J Biol Chem, 265, 5897-902.
Tachibana M. Miyakawa A, Tazaki H, et al. 1995, Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte-colony stimulating factor. Cancer Res, 55, 3438-43.
Satoh H, Abe Y, Katoh Y, et al.1993, Bladder carcinoma producing granulocyte colony-stimulating factor: a case report. J Urol, 149, 843-5.
Safarians S, Rivera SP, Sternlicht MD, et al.1997, Ectopic G-CSF expression in human melanoma lines marks a trans-dominant pathway of tumor progression. Am J Pathol, 150, 949-62.
Dano K, Andreasen PA, Grondahl-Hansen J, et al.1985, Plasminogen activators, tissue degradation and cancer. Adv Cancer Res, 44, 139-266.
Hart PH, Vitti GF, Burgess DR, et al.1991, Activation of human monocytes by granulocyte-macrophage colony-stimulating factor: increased urokinase-type plasminogen activator activity. Blood, 77, 841-8.
Stacey KJ, Fowles LF, Colman MS, et al.1995, Regulation of urokinase-type plasminogen activator gene transcription by macrophage colony-stimulating factor. Mol Cell Biol, 15, 3430-41.
Keski-Oja J, Lohi J, Tuuttila A, et al.1992, Proteolytic processing of the 72,000-Da type IV collagenase by urokinase plasminogen activator. Exp Cell Res, 202, 471-6.
Schultz RM, Yu H and Zhang JY, 1992, The role of urokinase and urokinase inhibitor in tumor cell metastasis. Fibrinolysis, 6, 23-9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pei, XH., Nakanishi, Y., Takayama, K. et al. G-CSF increases secretion of urokinase-typeplasminogen activator by human lung cancer cells. Clin Exp Metastasis 16, 551–558 (1998). https://doi.org/10.1023/A:1006546402703
Issue Date:
DOI: https://doi.org/10.1023/A:1006546402703